<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27-molecules-23-01857" class="ref">
 <label class="label">27.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Qi</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Xin</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Guo</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Diao</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kou</surname>
    <given-names class="given-names">X.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Luo</surname>
    <given-names class="given-names">L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Yin</surname>
    <given-names class="given-names">Z.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-ÎºB signaling pathways</article-title>
  <source class="source">Int. Immunopharmacol.</source>
  <year class="year">2012</year>
  <volume class="volume">12</volume>
  <fpage class="fpage">278</fpage>
  <lpage class="lpage">287</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.intimp.2011.12.001</pub-id>
  <?supplied-pmid 22193240?>
  <pub-id pub-id-type="pmid" class="pub-id">22193240</pub-id>
 </element-citation>
</ref>
